how to keep weight off after tirzepatide Wean Without Gaining Weight: Medical Guide Tirzepatide Delivers Long-Term Weight Loss

GLP-1 medications are not approved to treat addictive behaviors

1 In adults with obesity, along with diet and exercise, A well-studied safety profile for adults with obesity: Pooled safety data from 2 weight-management clinical trials evaluating Wegovy HD 7.2 mg 1 Wegovy HD (semaglutide) injection 7.2 mg had a safety profile consistent with Wegovy 2.4 mg 1,3 5% of patients with Wegovy HD 7.2 mg pen, 5% of patients with Wegovy 2.4 mg pen, and 2% of patients with placebo permanently discontinued as a result of adverse reactions 1 The most common adverse reactions leading to discontinuation were gastrointestinal disorders: 3% of patients with Wegovy HD 7.2 mg pen, 3% of patients with Wegovy 2.4 mg pen, and 0.3% of patients with placebo 1 Includes allodynia, burning sensation, dysesthesia, hyperesthesia, hyperpathia, pain of skin, paresthesia, sensitive skin, skin burning sensation, skin discomfort, and skin sensitization

Se llevan a cabo actividades manipulativas, estimulaciones multisensoriales, esquema corporal, integracin social Buscamos la autodeterminacin en la medida de lo posible de cada persona

Limit Exposure to Toxins Reducing exposure to environmental toxins, such as pollutants and heavy metals, can help minimize oxidative stress on the body